agilon health Q3 revenue +52% to $695M, medical margin up 74%, raises FY2022 guidance

agilon health, inc.

Revenue $695M (+52% YoY); total platform members 356,000 with 266,600 MA members (+45%).
Medical margin $76M (+74% YoY); margin rate 10.9% vs 9.5% prior year.
Net loss $31M vs $36M; Adjusted EBITDA -$5M vs -$14M (nine-month Adj. EBITDA positive $15M).
FY2022 guidance raised: revenue $2.674-2.683B, medical margin $300-309M, Adj. EBITDA $2-7M.
Cash and marketable securities $959M, total debt $45M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

agilon health, inc. reported financial results for the third quarter ended September 30, 2022.

Period: the third quarter ended September 30, 2022
Result: reported results

Exact text from the filing

On November 3, 2022, agilon health, inc., a Delaware corporation, issued a press release setting forth its financial results for the three and nine months ended September 30, 2022.

View on SEC.gov

Browse all earnings releases →

agilon health, inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-021889

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.